Avian influenza virus hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties and vaccine potential

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 989-996

  Yang, Ding Gang ^a   Chung, Yao Chi ^a   Lai, Yiu Kay ^a   Lai, Chia Wei ^a   Liu, Hung Jen ^b   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN GP 64; HISTIDINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVIAN INFLUENZA; BACULOVIRUS; CELL MEMBRANE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOGOLD ELECTRON MICROSCOPY; INSECT CELL; MAMMAL CELL; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; BIRDS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; GREEN FLUORESCENT PROTEINS; HELA CELLS; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; ORTHOMYXOVIRIDAE INFECTIONS; POLYMERASE CHAIN REACTION; SPODOPTERA; TRANSDUCTION, GENETIC; VIRAL PROTEINS;

AVES; AVIAN INFLUENZA VIRUS; MAMMALIA;

EID: 34247235806     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.sj.6300131     Document Type: Article

References (50)

1. Brown, EG (2000). Influenza virus genetics. Biomed Pharmacother 54: 196-209.
2. Webby, RJ, Perez, DR, Coleman, JS, Guan, Y, Knight JH, Govorkova, EA et al. (2004). Responsiveness to a pandemic alert: Use of reverse genetics for rapid development of influenza vaccines. Lancet 363: 1099-1103.
3. Lee, CW, Senne, DA and Suarez, DL (2004). Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22: 3175-3181.
4. Desselberger, U Nakajima K, Alfino P, Pedersen FS, Haseltine WA, Hannoun C et al. (1978). Biochemical evidence that 'new' influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci USA 75: 3341-3345.
5. Treanor, JJ, Wilkinson, BE, Masseoud, F, Hu-Primmer, J, Battaglia, R, O'Brien, D et al. (2001). Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19: 1732-1737.
6. Swayne, DE, Beck JR and Kinney, N (2000). Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis 44: 132-137.
7. Hu, YC (2005). Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26: 405-416.
8. Monsma, SA, Oomens, AGP and Blissard, GW (1996). The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection: J Virol 70: 4607-4616.
9. Kitagawa, Y, Tani, H, Limn, CK, Matsunaga, TM, Moriishi, K and Matsuura, Y (2005). Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 79: 3639-3652.
10. Oomens, AG and Blissard, GW (1999). Requirement for GP64 to drive efficient budding of Autographa californica multicapsid nucleopolyhedrovirus. Virology 254: 297-314.
11. Boublik, Y, Di Bonito, P and Jones, IM (1995). Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology 13: 1079-1084.
12. Yoshida, S, Kondoh, D, Arai, E, Matsuoka, H, Seki, C, Tanaka, T et al. (2003). Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 316: 161-170.
13. Tami, C, Peralta, A, Barbieri, R, Berinstein, A, Carrillo, E and Taboga, O. (2004). Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces. Vaccine 23: 840-845.
14. Schnell, MJ, Buonocore, L, Boritz, E, Ghosh, HP, Chemish, R and Rose, JK (1998). Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. EMBO J 17: 1289-1296.
15. Hu, YC, Tsai, CT, Chang, YJ and Huang, JH (2003). Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 19 373-379.
16. Kost, TA and Condreay, JP (1999). Recombinant baculoviruses as expression vectors for insect and mammalian cells. Curr Opin Biotechnol 10: 428-433.
17. Mottershead, D, van der Linden, I, von Bonsdorff, CH, Keinanen, K and Oker-Blom, C (1997). Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. Biochem Biophys Res Commun 238: 717-722.
18. Mottershead, DG, Alfthan, K, Ojala, K, Takkinen, K and Oker-Blom, C (2000). Baculoviral display of functional scFv and synthetic IgG-binding domains. Biochem Biophys Res Commun 275: 84-90.
19. Kaikkonen, MU, Raty, JK, Airenne, KJ, Wirth, T, Heikura, T and Yla-Herttuala, S (2006). Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther 13: 304-312.
20. Chapple, SDJ and Jones, IM (2002). Non-polar distribution of green fluorescent protein on the surface of Autographa californica nucleopolyhedrovirus using a heterologous membrane anchor. J Biotechnol 95: 269-275.
21. Borg, J, Nevsten, P, Wallenberg, R, Stenstrom, M, Cardell, S, Falkenberg, C et al. (2004). Amino-terminal anchored surface display in insect cells and budded baculovirus using the amino-terminal end of neuraminidase. J Biotechnol 114: 21-30.
22. Ernst, W, Grabherr, R, Wegner, D, Borth, N, Grassauer, A and Katinger, H (1998). Baculovirus surface display: Construction and screening of a eukaryotic epitope library. Nucleic Acids Res 26: 1718-1723.
23. Takimoto, T, Bousse, T, Coronel, EC, Scroggs, RA and Portner, A (1998). Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol 72: 9747-9754.
24. Yao, Q and Compans, RW (1995). Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins. J Virol 69: 7045-7053.
25. + cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. J Virol 71: 5060-5068.
26. Mebatsion, T, Konig, M and Conzelmann, KK (1996). Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 84: 941-951.
27. Oomens, AG and Wertz, GW (2004). The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J Virol 78: 124-135.
28. Tani, H, Nishijima, M, Ushijima, H, Miyamura, T and Matsuura, Y (2001). Characterization of cell-surface determinants important for baculovirus infection. Virology 279: 343-353.
29. Takeda, M, Leser, GP, Russel, CJ and Lamb, RA (2003). Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA 100: 14610-14617.
30. Veit, M, Kretzschmar, E, Kuroda, K, Garten, W, Schmidt, MF, Klenk, HD et al. (1991). Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin. J Virol 65: 2491-2500.
31. Scheiffele, P, Rietveld, A, Wilk, T and Simons, K (1999). Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem 274: 2038-2044.
32. Zhang, SX, Han, Y and Blissard, GW (2003). Palmitoylation of the Autographa californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: Mapping, functional studies, and lipid rafts. J Virol 77: 6265-6273.
33. Blissard, GW and Rohrmann, GF (1989). Location, sequence, transcriptional mapping, and temporal expression of the gp64 envelope glycoprotein gene of the Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus. Virology 170: 537-555.
34. Spenger, A, Grabherr, R, Tollner, L, Katinger, H and Ernst, W (2002). Altering the surface properties of baculovirus Autographa californica NPV by insertional mutagenesis of the envelope protein gp64. Eur J Biochem 269: 4458-4467.
35. Spies, CP, Ritter, GD, Jr., Mulligan, MJ and Compans, RW (1994). Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68: 585-591.
36. Matilainen, H, Rinne, J, Gilbert, L, Marjomaki, V, Reunanen, H and Oker-Blom, C (2005). Baculovirus entry into human hepatoma cells. J Virol 79: 15452-15459.
37. Pushko, P, Tumpey, TM, Bu, F, Knell, J, Robinson, R and Smith, G (2005). Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 23: 5751-5759.
38. Takada, A, Kuboki, N, Okazaki, K, Ninomiya, A, Tanaka, H, Ozaki, H et al. (1999). Avirulent avian influenza virus as a vaccine strain against a potential human pandemic. J Virol 73: 8303-8307.
39. Facciabene, A, Aurisicchio, L and La Monica, N (2004). Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 78: 8663-8672.
40. Broer, R, Boson, B, Spaan, W, Cosset FL and Corver, J (2006). Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J Virol 80: 1302-1310.
41. Kost TA, Condreay, JP and Jarvis, DL (2005). Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 23: 567-575.
42. Ping, W, Ge, J, Li, S, Zhou, H, Wang, K, Feng, Y et al. (2006). Baculovirus-mediated gene expression in chicken primary cells. Avian Dis 50: 59-63.
43. Johansson, BE, Matthews, JT and Kilbourne, ED (1998). Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 16 1009-1015.
44. Hu, YC, Liu, HJ and Chung, YC (2002). High level expression of the key antigenic protein, σC, from avian reovirus into insect cells and its purification by immobilized metal affinity chromatography. Biotechnol Lett 24: 1017-1022.
45. Hu, YC, Luo, YL, Ji, WT, Chulu, JL, Chang, PC, Shieh, H et al. (2006). Dual expression of the HA protein of H5N2 avian influenza virus in a baculovirus system. J Virol Methods 135: 43-48.
46. Hu, Y-C, Tsai, C-T, Chung, Y-C, Lu, J-T and Hsu, JT-A (2003). Generation of chimeric baculovirus with histidine-tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb Technol 33: 445-452.
47. Chan, ZR, Lai, CW, Lee, HP, Chen, HC and Hu, YC (2006). Determination of the baculovirus transducing titer in mammalian cells. Biotechnol Bioeng 93: 564-571.
48. O'Reilly, D, Miller, L and Luckow, V (1992). Baculovirus Expression Vectors: A Laboratory Manual. W.H. Freeman and Co.: New York.
49. Wang, KC, WU, JC, Chung, YC, Ho, YC, Chang, MD and Hu YC (2005). Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 89: 464-473.
50. Coligan, JE, Bierer, BE, Margulies, DH, Shevach, EM and Strober, W (2005). Short Protocols in Immunology. John Wiley & Sons: New York.